Nexalin Technology, Inc. (NXLIW)
NASDAQ: NXLIW · Real-Time Price · USD · Warrants
0.0450
-0.0300 (-40.00%)
Aug 27, 2025, 4:00 PM - Market closed
Company Description
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China.
The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer’s disease, and dementia.
Nexalin Technology, Inc. is headquartered in Houston, Texas.
Nexalin Technology, Inc.
| Country | United States |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Mark White |
Contact Details
Address: 1776 Yorktown, Suite 550 Houston, Texas 77056 United States | |
| Phone | 832 260 0222 |
| Website | nexalin.com |
Stock Details
| Ticker Symbol | NXLIW |
| Exchange | NASDAQ |
| Stock Type | Warrants |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001527352 |
| CUSIP Number | 65345B110 |
| ISIN Number | US65345B1109 |
Key Executives
| Name | Position |
|---|---|
| Mark White | President, Chief Executive Officer and Director |
| Carolyn Shelton | Executive Vice President of Clinical, Quality and Regulatory Affairs and Chief Operating Officer |
| Dr. David Owens M.D. | Chief Medical Officer, Member of Scientific Advisory Board and Director |
| Marilyn Elson | Controller |
| John Patrick Claude | Co-Founder and Director of Engineering and Development |
| Justin Van Fleet CPA | Chief Financial Officer |